Seeking Alpha

Valeant Pharmaceuticals Intl (VRX)

()

News & PR
Market Currents

Buzz
Twitter: VRX

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Klarman, Whitman Are Sellers But Witmer Buys in Q3 2009

Nov 18 • Davy Bui • Comment!
37 Breakout Stocks on Big Volume, November 16, 2009

Nov 17 • Marco Hickey • 2 Comments
Valeant: It Turns Out that Wrinkles Are Worth Quite a Lot

Nov 2 • Carol Flake Chapman • Comment!
Tupperware: Unlikely Market Leader

Oct 14 • Jeff Pierce • Comment!
Best Performing Mid and Small Cap Stocks Since 10/9/07 Peak

Oct 9 • Bespoke Investment Group • 1 Comment
Top Option Trades from September 30

Oct 1 • Joe Kunkle • 2 Comments
Wednesday Options Recap

Sep 30 • Frederic Ruffy • 1 Comment
Biotech News Bytes: Neuralstem, Questcor, Valeant, Impax

Sep 21 • Mike Havrilla • 1 Comment
Valeant's Six New Value Aligned Pay Practices

Sep 3 • Value Expectations • 1 Comment
Valeant’s Pain Drug Disappoints

Aug 25 • Zacks.com • Comment!
Wall Street Breakfast: Must-Know News

Aug 4 • SA Editor Rachael Granby • 7 Comments
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch

Jun 28 • Marco Hickey • 1 Comment
Merck Short Base Rising

Jun 10 • Data Explorers • Comment!
Life Science Companies Get Boost from Capital Markets

Jun 7 • The Burrill Report • 2 Comments
Notable Picks from Investment Managers - Barron's

May 31 • SA Editor Rachael Granby • 9 Comments
Wall Street Breakfast: Must-Know News

May 5 • SA Editor Rachael Granby • 15 Comments
Possible Swine Flu Profit Trades

Apr 27 • Marco Hickey • 9 Comments
Wall Street Breakfast: Must-Know News

Feb 24 • SA Editor Rachael Granby • 13 Comments
Little Rays of Sunshine in the Markets

Feb 6 • Richard Shaw • 3 Comments
It's Not Just About Getting High - Seven Marijuana Stocks

Jan 21 • Stockerblog • 5 Comments
Looking for the Biotech Breakout

Jan 19 • Jeff Pierce • 5 Comments
Hedge Fund Portfolio Tracking: D.E. Shaw & Co (David E. Shaw), Q3 2008

Jan 16 • Market Folly • 1 Comment
2008 Stock Market: 51 Rays of Light

Jan 7 • Market Folly • 1 Comment
Cosmetic and Reconstructive Medicine ETF Outpaces Healthcare Sector

Nov 2, 2008 • Mike Havrilla • Comment!
Monday Options Outlook: AMZN, MCD, EL, CRME, VRX, CCK, CNO

Aug 11, 2008 • Andrew Wilkinson • 1 Comment
Stocks At or Near 52-Week Highs

Aug 7, 2008 • Bespoke Investment Group • 3 Comments
Valeant Pharma Sells Costly Asian Operations

Mar 4, 2008 • ChinaBio Today • Comment!
7 Companies Searching to Treat or Cure Parkinson's

Apr 25, 2007 • Stockerblog • 1 Comment
Biotech Stock Review: GPC Biotech Completes New Drug Approval

Feb 20, 2007 • Centient Biotech Investor • Comment!
Biotech Stocks Day-in-Review: Genentech Closes Third Deal This Week

Jan 14, 2007 • Centient Biotech Investor • Comment!
Options Backdating Issues at Integrated Silicon, Valeant Pharma

Oct 24, 2006 • Jack Ciesielski • Comment!
Pharma IPO: Highlights from Obagi Medical's S-1 Filing

Sep 14, 2006 • Evelyn Rubin • Comment!
Investors No Longer Fazed by Bad News at Valeant

Sep 13, 2006 • Fredric Cohen, M.D. • Comment!

Valeant Pharmaceuticals Intl (VRX)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers